Executive Vice President and President, Merck Animal Health · Merck & Co., Inc. (MRK)

Richard DeLuca

A named executive officer of Merck in every fiscal year CompBrief holds from FY2021 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$9,098,531

Salary $958,747Stock awards $5,699,835

FY2023: $6,197,890

4th of 5 named executive officers at Merck by FY2024 total.

5 named officers on file for Merck, FY2024

Richard DeLuca’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 8 equity grants, each cited to its filing
  • MRK’s disclosed peer group of 12 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Merck’s whole pay program stands against its peers

  • Merck’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MRK→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 9, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Richard DeLuca’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Richard DeLuca compensation by year

Merck Summary Compensation Table · all 3 fiscal years held
In US dollars, as Merck reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2023FY2024
Salary$790,247$910,027$958,747
Bonus$0$0$0
Stock awards$3,856,115$2,369,846$5,699,835
Option awards$809,999$959,999$960,000
Non-equity incentive$1,184,000$1,369,000$1,096,680
Pension and deferred compensation$128,732$470,087$268,758
All other$71,907$118,931$114,511
Total$6,841,000$6,197,890$9,098,531

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Merck & Co., Inc. DEF 14A filed April 9, 2025, accession 0001193125-25-076859, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Merck & Co., Inc. filed document, accession 0001193125-25-076859. Every figure is read from that document and cited to the page and table it appears in. Filed April 9, 2025.

$6.8M
$6.2M
$9.1M
FY21
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
PSU42,110$4,189,103—
PSU33,952$3,377,545—
RSU23,216$2,309,528—
Option19,418—$87.10
Option29,507—$117.89
Option37,500—$129.22

Per the Outstanding Equity Awards at Fiscal Year-End table in Merck & Co., Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

20 Form 4 lines since the FY2024 proxy (filed April 9, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-11-12Sale—58,185$148.01112,955.43
2026-11-12Exercise or conversion derivative—58,185$0.000
2026-11-12Exercise or conversion—58,185$77.62171,140.43
2026-08-12Sale—11,099$131.61110,767.07
2026-08-12Sale—600$132.04110,167.07
2026-08-11Sale—5,427$132.35121,866.07
2026-08-11Sale—7,410$131.33127,293.07
2026-08-10Sale—20,784$130.43134,703.07

The 8 most recent of 20 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Merck’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Robert DavisChairman, Chief Executive Officer and President$23,186,064
Betty LarsonExecutive Vice President and Chief Human Resources Officer$11,257,796
Dean LiExecutive Vice President and President, Merck Research Laboratories$10,086,332
Richard DeLuca · this pageExecutive Vice President and President, Merck Animal Health$9,098,531
Caroline LitchfieldExecutive Vice President and Chief Financial Officer$7,507,778

The full Merck compensation record

free company brief

This page is one person within Merck's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Merck proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Merck's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Richard DeLuca's compensation dossier · One-time report. No refunds.